Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - LONG-TERM DEBT
Long-term Debt RPRX - Royalty Pharma plc
6.14 B
LAST VALUE
-7.02%
2 YEAR CAGR
-0.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR